Differential gene expression pattern of diabetic rat retinas after intravitreal injection of erythropoietin

Clinical and Experimental Ophthalmology

Volumn 39, Issue 2, 2011, Pages 142-151

  Chu, Qing ^a   Zhang, Jingfa ^b   Wu, Yalan ^a   Zhang, Yu ^c   Xu, Guoxu ^d   Li, Weiye ^a,b,e   Xu, Guo Tong ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c FUDAN UNIVERSITY   (China)

^d THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^e DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Diabetic retinopathy; Erythropoietin.

Indexed keywords

ERYTHROPOIETIN; INTERLEUKIN 11; INTERLEUKIN 2; RNA; STREPTOZOCIN;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; GENE EXPRESSION; INFLAMMATION; MALE; MICROARRAY ANALYSIS; NONHUMAN; RAT; REAL TIME POLYMERASE CHAIN REACTION; RETINA; RNA EXTRACTION; SPRAGUE DAWLEY RAT; STREPTOZOCIN DIABETES; UPREGULATION;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DNA PRIMERS; ERYTHROPOIETIN; EYE PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INTRAVITREAL INJECTIONS; MALE; PROTEIN ARRAY ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 79952684029     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2010.02437.x     Document Type: Article

References (42)

1. Barber AJ. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 283-90.
2. Abu-El-Asrar AM, Dralands L, Missotten L. Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophthalmol Vis Sci 2004; 45: 2760-6.
3. Lieth E, Gardner TW, Barber AJ, Antonetti DA. Retinal neurodegeneration: early pathology in diabetes. Clin Experiment Ophthalmol 2000; 28: 3-8.
4. Gardner TW, Antonetti DA, Barber AJ etal. Diabetic retinopathy: more than meets the eye. Surv Ophthalmol 2002; 47 (Suppl. l2): S253-62.
5. Zhang J-F, Dai W, Yanoff M, Li W, Xu G-T. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Invest Ophthalmol Vis Sci 2008; 49: 732-42.
6. Chong ZZ, Kang J-Q, Maiese K. Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation 2002; 106: 2973-9.
7. Ghezzi P, Brines M. Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ 2002; 11 (Suppl. 1): S37-44.
8. Buemi M, Cavallaro E, Floccari F etal. The pleiotropic effects of erythropoietin in the central nervous system. J Neuropathol Exp Neurol 2003; 62: 228-36.
9. Zhong L, Bradley J, Schubert W etal. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Invest Ophthalmol Vis Sci 2007; 48: 1212-18.
10. Shen J-F, Wu Y-L, Zhang J-F etal. ERK- and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD. Invest Ophthalmol Vis Sci 2009; 51: 35-46.
11. Lei X, Zhang J, Shen J etal. EPO attenuates inflammatory cytokines by Muller cells in diabetic retinopathy. Front Biosci (Elite Ed) 2011; 3: 201-11.
12. Winkler AS, Marsden J, Chaudhuri KR, Hambley H, Watkins PJ. Erythropoietin depletion and anaemia in diabetes mellitus. Diabet Med 1999; 16: 813-19.
13. Friedman EA, L'Esperance FA, Brown CD etal. Treating azotemia-induced anemia with erythropoietin improves diabetic eye disease. Kidney Int Suppl 2003; S57-63.
14. Sinclair SH, DelVecchio C, Levin A. Treatment of anemia in the diabetic patient with retinopathy and kidney disease. Am J Ophthalmol 2003; 135: 740-3.
15. Li W, Sinclair SH, Xu G-T. Effects of intravitreal erythropoietin therapy for patients with chronic and progressive diabetic macular edema. Ophthalmic Surg Lasers Imaging 2010; 41: 18-25.
16. Kim SJ, Kim S, Park J etal. Differential expression of vitreous proteins in proliferative diabetic retinopathy. Curr Eye Res 2006; 31: 231-40.
17. Joussen AM, Huang S, Poulaki V etal. In vivo retinal gene expression in early diabetes. Invest Ophthalmol Vis Sci 2001; 42: 3047-57.
18. Gerhardinger C, Costa MB, Coulombe MC etal. Expression of acute-phase response proteins in retinal Muller cells in diabetes. Invest Ophthalmol Vis Sci 2005; 46: 349-57.
19. Harris MA, Clark J, Ireland A etal. Gene Ontology consortium. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 2004; 32 (Database issue): D258-261.
20. Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000; 28: 27-30.
21. Brucklacher RM, Patel KM, VanGuilder HD etal. Whole genome assessment of the retinal response to diabetes reveals a progressive neurovascular inflammatory response. BMC Med Genomics 2008; 1: 26.
22. Ng EW, Shima DT, Calias P, Cunningham ET Jr, Guyer DR, Adamis AP. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat Rev Drug Discov 2006; 5: 123-32.
23. Herold K, Moser B, Chen Y etal. Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress. J Leukoc Biol 2007; 82: 204-12.
24. Aiello LP. The potential role of PKC beta in diabetic retinopathy and macular edema. Surv Ophthalmol 2002; 2: S263-9.
25. Caldwell RB, Bartoli M, Behzadian MA etal. Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress. Curr Drug Targets 2005; 6: 511-24.
26. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005; 115: 1111-19.
27. Antonetti DA, Barber AJ, Bronson SK etal. Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 2006; 55: 2401-11.
28. Beaudette-Zlatanova BC, Whalen B, Zipris D etal. Costimulation and autoimmune diabetes in BB rats. Am J Transplant 2006; 6: 894-902.
29. Wang R, Han G, Wang J etal. GAD-IgG-inducing CD4+Foxp3+Treg cells suppressing diabetes are involved in the increasing ratio of CD80+:CD86+ CELLS in NOD mice. Arch Med Res 2008; 39: 299-305.
30. Bohmova K, Haldikova Z, Cerny M etal. Cord blood cytokine profile detection in neonates with T1D parents - monitoring of cellular auto-reactivity using protein microarray. Scand J Immunol 2007; 66: 563-71.
31. Gurfein BT, Zhang Y, López CB etal. IL-11 regulates autoimmune demyelination. J Immunol 2009; 183: 4229-40.
32. Jackson A, McWilliams C, Kaizer E etal. Gene expression profiling of human pancreatic islets undergoing a simulated process of instant blood-mediated inflammatory reaction. Transplant Proc 2008; 40: 430-2.
33. Chistiakov DA, Voronova NV, Chistiakov PA. The crucial role of IL-2/IL-2RA-mediated immune regulation in the pathogenesis of type 1 diabetes, an evidence coming from genetic and animal model studies. Immunol Lett 2008; 118: 1-5.
34. Kolla VK, Madhavi G, Pulla Reddy B etal. Association of tumor necrosis factor alpha, interferon gamma and interleukin 10 gene polymorphisms with peripheral neuropathy in South Indian patients with type 2 diabetes. Cytokine 2009; 47: 173-7.
35. Reed JC. Mechanisms of Bcl-2 family protein function and dysfunction in health and disease. Behring Inst Mitt 1996; 97: 72-100.
36. Chinnadurai G, Vijayalingam S, Rashmi R. BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes. Oncogene 2008; 27 (Suppl. 1): S20-9.
37. Gerhardinger C, Costa MB, Coulombe MC, Toth I, Hoehn T, Grosu P. Expression of acute-phase response proteins in retinal Müller cells in diabetes. Invest Ophthalmol Vis Sci 2005; 46: 349-57.
38. Gray S II, Davis KR, Donnelly R. Increased skeletal muscle expression of PKC-theta but not PKC-alpha mRNA in type 2 diabetes: inverse relationship with in-vivo insulin sensitivity. Eur J Clin Invest 2003; 33: 983-7.
39. Parsons-Wingerter P, Radhakrishnan K, Vickerman MB, Kaiser PK. Oscillation of angiogenesis with vascular dropout in diabetic retinopathy by VESsel GENeration Analysis (VESGEN). Invest Ophthalmol Vis Sci 2009; 51: 498-507.
40. Chung HK, Choi SM, Ahn BO etal. Efficacy of troxerutin on streptozotocin-induced rat model in the early stage of diabetic retinopathy. Arzneimittelforschung 2005; 55: 573-80.
41. Hammes HP, Lin J, Bretzel RG, Brownlee M, Breier G. Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. Diabetes 1998; 47: 401-6.
42. Zhang J, Hu L, Xu G etal. Anti-VEGF effects of intravitreal injection of erythropoietin through negative feedback regulation in early diabetic retinopathy. Front Biosci (Elite Ed) 2010; 2: 912-17.